We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Prof
Thomas
Pinkney
+44 (0)121 414 9012
thomas.pinkney@uhb.nhs.uk
Dr
Rita
Perry
+44 (0)121 414 9106
r.perry.1@bham.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Parastomal hernia (PSH) treatment
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
PROPHER stands for Patient Reported Outcomes after Parastomal Hernia Treatment. The overall aim of the PROPHER study is to see what the impact on the patient’s quality of life is from having treatment for a parastomal hernia. The study will also look at how parastomal hernias are treated, for example having an operation and any complications that happen in the first 30 days, or deciding to “watch and wait”. It will also look at whether there are any links between the way that a surgeon repairs a parastomal hernia and the outcomes.
What is a parastomal hernia? Stoma formation is often necessary after bowel surgery. A common complication of a stoma is a parastomal hernia (PSH) - caused by a weakness in the abdominal muscle which results in a local bulge next to or behind the stoma. A PSH can cause skin irritation, problems with getting a stoma bag to stick, as well as pain and other more serious complications such as bowel obstruction. These issues often have a negative impact on a patient’s quality of life.
What are patient-reported outcomes? Patient-reported outcome measures (PROMs) are questionnaires that measure the patient’s view of their own health. Questionnaires are completed before and after treatment so that healthcare professionals and researchers can see how the treatment has impacted the patient.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
1. Patients with an isolated urostomy2. Life expectancy less than 12 months3. Proposed treatment plan for dealing with PSH involves restoration of gut continuity meaning that patient will have no stoma after treatment.4. Anyone who does not have an email address or does not have access to the internet or a smart device
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Rita
Perry
+44 (0)121 414 9106
r.perry.1@bham.ac.uk
Prof
Thomas
Pinkney
+44 (0)121 414 9012
thomas.pinkney@uhb.nhs.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by University of Birmingham and funded by Bowel Research UK; European Society of Coloproctology.
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Or CPMS 52007
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
